Benefit of adjuvant, but not concurrent, temozolomide for IDH-mutant anaplastic astrocytoma

Research output: Contribution to journalComment/debatepeer-review

1 Citation (Scopus)
Original languageEnglish
Pages (from-to)743-744
Number of pages2
JournalThe Lancet Oncology
Volume22
Issue number6
DOIs
Publication statusPublished - 2021 Jun

ASJC Scopus subject areas

  • Oncology

Cite this